Polymorphic variations of this gene in patients with PCOS have been associated with increased FSH concentrations (44) and resistance to exogenous ovarian stimulation with gonadotrophins and clomiphene (54). The gene discussed is BRD2; the disease is polycystic ovary syndrome.